New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 25, 2023 - Tarsus announced the FDA approval of Xdemvy (lotilaner), for the treatment of Demodex blepharitis.
Download PDF
Return to publications
